Abstract
Nerve injury is known to produce neuropathic pain by inducing changes not only in neurons such as primary sensory neurons in the dorsal root ganglion (DRG), but also in non-neuronal cells such as microglia in the spinal cord. Increasing evidence suggests that mitogen-activated protein kinases (MAPKs) play important roles in neuropathic pain sensitization by regulating intracellular signaling in both DRG neurons and spinal cord microglia. Intrathecal injection of MAPK inhibitors for the extracellular signal-regulated kinase (ERK), p38, or c-Jun N-terminal kinase (JNK) pathway targets the MAPK pathways at both DRG and spinal cord levels and has been shown to attenuate neuropathic pain in different animal models. In particular, activation of p38 in DRG neurons by nerve growth factor and cytokines contributes to thermal hypersensitivity by increasing the expression and activity of sodium channels (e.g., Nav1.7/Nav1.8) and TRP channels (e.g., TRPV1 and TRPA1). Activation of p38 in spinal microglia by chemokines, cytokines, ATP, and proteases also contributes to neuropathic pain symptoms such as mechanical allodynia. Thus, activation of MAPK pathways in both neurons and glia and in both the peripheral and central nervous system is important for neuropathic pain sensitization, and blocking these pathways at multiple sites may lead to effective therapies for neuropathic pain.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Abbreviations
- AMPA:
-
α-amino-2,3-dihydro-5-methyl-3-oxo-4-isoxazolepropanic acid
- BDNF:
-
brain-derived neurotrophic factor
- CatS:
-
cysteine protease cathepsin S
- DRG:
-
dorsal root ganglion
- GABA:
-
gamma aminobutyric acid
- ERK:
-
extracelllular signal-regulated kinase
- bFGF:
-
basic fibroblast growth factor
- FKN:
-
fractalkine
- IL-1:
-
Interleukin-1
- JNK:
-
c-Jun-N-terminal kinase
- MAPK:
-
mitogen-activated protein kinases
- MCP-1:
-
monocyte chemoattractant protein-1
- NMDA:
-
N-methyl-d-aspartate
- MMP-9:
-
matrix metalloproteinase-9
- NGF:
-
nerve growth factor
- NT-3:
-
neurotrophin 3
- PGE2:
-
prostaglandin E2
- PTN:
-
pain transmission neurons STZ, streptozotocin
- TNF:
-
tumor necrosis factor
- TRP:
-
transient receptor potential
References
Abbadie, C., Lindia, J.A., Cumiskey, A.M., Peterson, L.B., Mudgett, J.S., Bayne, E.K., DeMartino, J.A., MacIntyre, D.E., and Forrest, M.J. (2003). Impaired neuropathic pain responses in mice lacking the chemokine receptor CCR2. Proc. Natl. Acad. Sci. U.S.A. 100, 7947–7952.
Campbell, J.N. and Meyer, R.A. (2006). Mechanisms of neuropathic pain. Neuron 52, 77–92.
Chattopadhyay, M., Mata, M., and Fink, D.J. (2008). Continuous delta-opioid receptor activation reduces neuronal voltage-gated sodium channel (NaV1.7) levels through activation of protein kinase C in painful diabetic neuropathy. J. Neurosci. 28, 6652–6658.
Clark, A.K., D'Aquisto, F., Gentry, C., Marchand, F., McMahon, S.B., and Malcangio, M. (2006). Rapid co-release of interleukin 1beta and caspase 1 in spinal cord inflammation. J. Neurochem. 99, 868–880.
Clark, A.K., Yip, P.K., Grist, J., Gentry, C., Staniland, A.A., Marchand, F., Dehvari, M., Wotherspoon, G., Winter, J., Ullah, J., Bevan, S., and Malcangio, M. (2007). Inhibition of spinal microglial cathepsin S for the reversal of neuropathic pain. Proc. Natl. Acad. Sci. U.S.A. 104, 10655–10660.
Constantin, C.E., Mair, N., Sailer, C.A., Andratsch, M., Xu, Z.Z., Blumer, M.J., Scherbakov, N., Davis, J.B., Bluethmann, H., Ji, R.R., and Kress, M. (2008). Endogenous tumor necrosis factor alpha (TNFalpha) requires TNF receptor type 2 to generate heat hyperalgesia in a mouse cancer model. J. Neurosci. 28, 5072–5081.
Costigan, M., Befort, K., Karchewski, L., Griffin, R.S., D'Urso, D., Allchorne, A., Sitarski, J., Mannion, J.W., Pratt, R.E., and Woolf, C.J. (2002). Replicate high-density rat genome oligonucleotide microarrays reveal hundreds of regulated genes in the dorsal root ganglion after peripheral nerve injury. BMC. Neurosci. 3, 16.
Coull, J.A., Beggs, S., Boudreau, D., Boivin, D., Tsuda, M., Inoue, K., Gravel, C., Salter, M.W., and De Koninck, Y. (2005). BDNF from microglia causes the shift in neuronal anion gradient underlying neuropathic pain. Nature 438, 1017–1021.
Coull, J.A., Boudreau, D., Bachand, K., Prescott, S.A., Nault, F., Sik, A., De Koninck, P., and De Koninck, Y. (2003). Trans-synaptic shift in anion gradient in spinal lamina I neurons as a mechanism of neuropathic pain. Nature 424, 938–942.
DeLeo, J.A. and Yezierski, R.P. (2001). The role of neuroinflammation and neuroimmune activation in persistent pain. Pain 90, 1–6.
Devor, M. (1991). Neuropathic pain and injured nerve: peripheral mechanisms. Br. Med. Bull. 47, 619–630.
Devor, M., Wall, P.D., and Catalan, N. (1992). Systemic lidocaine silences ectopic neuroma and DRG discharge without blocking nerve conduction. Pain 48, 261–268.
Djouhri, L., Koutsikou, S., Fang, X., McMullan, S., and Lawson, S.N. (2006). Spontaneous pain, both neuropathic and inflammatory, is related to frequency of spontaneous firing in intact C-fiber nociceptors. J. Neurosci. 26, 1281–1292.
Fukuoka, T., Kondo, E., Dai, Y., Hashimoto, N., and Noguchi, K. (2001). Brain-derived neurotrophic factor increases in the uninjured dorsal root ganglion neurons in selective spinal nerve ligation model. J. Neurosci. 21, 4891–4900.
Hains, B.C. and Waxman, S.G. (2006). Activated microglia contribute to the maintenance of chronic pain after spinal cord injury. J. Neurosci. 26, 4308–4317.
Hokfelt, T., Zhang, X., and Wiesenfeld-Hallin, Z. (1994). Messenger plasticity in primary sensory neurons following axotomy and its functional implications. Trends Neurosci. 17, 22–30.
Hudmon, A., Choi, J.S., Tyrrell, L., Black, J.A., Rush, A.M., Waxman, S.G., and Dib-Hajj, S.D. (2008). Phosphorylation of sodium channel Na(v)1.8 by p38 mitogen-activated protein kinase increases current density in dorsal root ganglion neurons. J. Neurosci. 28, 3190–3201.
Ji, R.R., Kawasaki, Y., Zhuang, Z.Y., Wen, Y.R., and Zhang, Y.Q. (2007). Protein kinases as potential targets for the treatment of pathological pain. Handb. Exp. Pharmacol. 359–389.
Ji, R.R., Samad, T.A., Jin, S.X., Schmoll, R., and Woolf, C.J. (2002). p38 MAPK activation by NGF in primary sensory neurons after inflammation increases TRPV1 levels and maintains heat hyperalgesia. Neuron 36, 57–68.
Ji, R.R. and Strichartz, G. (2004). Cell signaling and the genesis of neuropathic pain. Sci. STKE. 2004, reE14.
Ji, R.R. and Suter, M.R. (2007). p38 MAPK, microglial signaling, and neuropathic pain. Mol. Pain 3, 33.
Ji, R.R. and Woolf, C.J. (2001). Neuronal plasticity and signal transduction in nociceptive neurons: implications for the initiation and maintenance of pathological pain. Neurobiol. Dis. 8, 1–10.
Ji, R.R., Zhang, Q., Zhang, X., Piehl, F., Reilly, T., Pettersson, R.F., and Hokfelt, T. (1995). Prominent expression of bFGF in dorsal root ganglia after axotomy. Eur. J. Neurosci. 7, 2458–2468.
Jin, X. and Gereau, R.W. (2006). Acute p38-mediated modulation of tetrodotoxin-resistant sodium channels in mouse sensory neurons by tumor necrosis factor-alpha. J. Neurosci. 26, 246–255.
Jin, S.X., Zhuang, Z.Y., Woolf, C.J., and Ji, R.R. (2003). p38 mitogen-activated protein kinase is activated after a spinal nerve ligation in spinal cord microglia and dorsal root ganglion neurons and contributes to the generation of neuropathic pain. J. Neurosci. 23, 4017–4022.
Kawasaki, Y., Zhang, L., Cheng, J.K., and Ji, R.R. (2008). Cytokine mechanisms of central sensitization: distinct and overlapping role of interleukin-1beta, interleukin-6, and tumor necrosis factor-alpha in regulating synaptic and neuronal activity in the superficial spinal cord. J. Neurosci. 28, 5189–5194.
Kehlet, H., Jensen, T.S., and Woolf, C.J. (2006). Persistent postsurgical pain: risk factors and prevention. Lancet 367, 1618–1625.
Kobayashi, K., Yamanaka, H., Fukuoka, T., Dai, Y., Obata, K., and Noguchi, K. (2008). P2Y12 receptor upregulation in activated microglia is a gateway of p38 signaling and neuropathic pain. J. Neurosci. 28, 2892–2902.
Kumar, S., Boehm, J., and Lee, J.C. (2003). p38 MAP kinases: key signalling molecules as therapeutic targets for inflammatory diseases. Nat. Rev. Drug Discov. 2, 717–726.
Ma, C., Shu, Y., Zheng, Z., Chen, Y., Yao, H., Greenquist, K.W., White, F.A., and LaMotte, R.H. (2003). Similar electrophysiological changes in axotomized and neighboring intact dorsal root ganglion neurons. J. Neurophysiol. 89, 1588–1602.
Ma, W., Zhang, Y., Bantel, C., and Eisenach, J.C. (2005). Medium and large injured dorsal root ganglion cells increase TRPV-1, accompanied by increased alpha2C-adrenoceptor co-expression and functional inhibition by clonidine. Pain 113, 386–394.
Moore, K.A., Kohno, T., Karchewski, L.A., Scholz, J., Baba, H., and Woolf, C.J. (2002). Partial peripheral nerve injury promotes a selective loss of GABAergic inhibition in the superficial dorsal horn of the spinal cord. J. Neurosci. 22, 6724–6731.
Obata, K., Katsura, H., Mizushima, T., Yamanaka, H., Kobayashi, K., Dai, Y., Fukuoka, T., Tokunaga, A., Tominaga, M., and Noguchi, K. (2005). TRPA1 induced in sensory neurons contributes to cold hyperalgesia after inflammation and nerve injury. J. Clin. Invest 115, 2393–2401.
Obata, K., Yamanaka, H., Kobayashi, K., Dai, Y., Mizushima, T., Katsura, H., Fukuoka, T., Tokunaga, A., and Noguchi, K. (2004). Role of mitogen-activated protein kinase activation in injured and intact primary afferent neurons for mechanical and heat hypersensitivity after spinal nerve ligation. J. Neurosci. 24, 10211–10222.
Pabbidi, R.M., Cao, D.S., Parihar, A., Pauza, M.E., and Premkumar, L.S. (2008). Direct role of streptozotocin in inducing thermal hyperalgesia by enhanced expression of transient receptor potential vanilloid 1 in sensory neurons. Mol. Pharmacol. 73, 995–1004.
Porreca, F., Ossipov, M.H., and Gebhart, G.F. (2002). Chronic pain and medullary descending facilitation. Trends Neurosci. 25, 319–325.
Raghavendra, V., Tanga, F., and DeLeo, J.A. (2003). Inhibition of microglial activation attenuates the development but not existing hypersensitivity in a rat model of neuropathy. J. Pharmacol. Exp. Ther. 306, 624–630.
Rush, A.M., Dib-Hajj, S.D., Liu, S., Cummins, T.R., Black, J.A., and Waxman, S.G. (2006). A single sodium channel mutation produces hyper- or hypoexcitability in different types of neurons. Proc. Natl. Acad. Sci. U.S.A. 103, 8245–8250.
Schafers, M., Lee, D.H., Brors, D., Yaksh, T.L., and Sorkin, L.S. (2003a). Increased sensitivity of injured and adjacent uninjured rat primary sensory neurons to exogenous tumor necrosis factor-alpha after spinal nerve ligation. J. Neurosci. 23, 3028–3038.
Schafers, M., Svensson, C.I., Sommer, C., and Sorkin, L.S. (2003b). Tumor necrosis factor-alpha induces mechanical allodynia after spinal nerve ligation by activation of p38 MAPK in primary sensory neurons. J. Neurosci. 23, 2517–2521.
Sung, C.S., Wen, Z.H., Chang, W.K., Chan, K.H., Ho, S.T., Tsai, S.K., Chang, Y.C., and Wong, C.S. (2005). Inhibition of p38 mitogen-activated protein kinase attenuates interleukin-1beta-induced thermal hyperalgesia and inducible nitric oxide synthase expression in the spinal cord. J. Neurochem. 94, 742–752.
Suter, M.R., Wen, Y.R., Decosterd, I., and Ji, R.R. (2007). Do glial cells control pain? Neuron Glia Biol. 3, 255–268.
Svensson, C.I., Fitzsimmons, B., Azizi, S., Powell, H.C., Hua, X.Y., and Yaksh, T.L. (2005a). Spinal p38beta isoform mediates tissue injury-induced hyperalgesia and spinal sensitization. J. Neurochem. 92, 1508–1520.
Svensson, C.I., Schafers, M., Jones, T.L., Powell, H., and Sorkin, L.S. (2005b). Spinal blockade of TNF blocks spinal nerve ligation-induced increases in spinal P-p38. Neurosci. Lett. 379, 209–213.
Sweitzer, S.M., Schubert, P., and DeLeo, J.A. (2001). Propentofylline, a glial modulating agent, exhibits antiallodynic properties in a rat model of neuropathic pain. J. Pharmacol. Exp. Ther. 297, 1210–1217.
Tang, H.B., Li, Y.S., Arihiro, K., and Nakata, Y. (2007). Activation of the neurokinin-1 receptor by substance P triggers the release of substance P from cultured adult rat dorsal root ganglion neurons. Mol. Pain 3, 42.
Trang, T., Beggs, S., Wan, X. and Salter, M.W., 2009. P2X4-receptor-mediated synthesis and release of brain-derived neurotrophic factor in microglia is dependent on calcium and p38-mitogen-activated protein kinase activation. J Neurosci. 29, 3518–3528.
Tsuda, M., Inoue, K., and Salter, M.W. (2005). Neuropathic pain and spinal microglia: a big problem from molecules in "small" glia. Trends Neurosci. 28, 101–107.
Tsuda, M., Mizokoshi, A., Shigemoto-Mogami, Y., Koizumi, S., and Inoue, K. (2004). Activation of p38 mitogen-activated protein kinase in spinal hyperactive microglia contributes to pain hypersensitivity following peripheral nerve injury. Glia 45, 89–95.
Tsuda, M., Shigemoto-Mogami, Y., Koizumi, S., Mizokoshi, A., Kohsaka, S., Salter, M.W., and Inoue, K. (2003). P2X4 receptors induced in spinal microglia gate tactile allodynia after nerve injury. Nature 424, 778–783.
Watkins, L.R., Martin, D., Ulrich, P., Tracey, K.J., and Maier, S.F. (1997). Evidence for the involvement of spinal cord glia in subcutaneous formalin induced hyperalgesia in the rat. Pain 71, 225–235.
Watkins, L.R., Milligan, E.D., and Maier, S.F. (2001). Glial activation: a driving force for pathological pain. Trends Neurosci. 24, 450–455.
Wen, Y.R., Suter, M.R., Kawasaki, Y., Huang, J., Pertin, M., Kohno, T., Berde, C.B., Decosterd, I., and Ji, R.R. (2007). Nerve conduction blockade in the sciatic nerve prevents but does not reverse the activation of p38 mitogen-activated protein kinase in spinal microglia in the rat spared nerve injury model. Anesthesiology 107, 312–321.
White, F.A., Jung, H., and Miller, R.J. (2007). Chemokines and the pathophysiology of neuropathic pain. Proc. Natl. Acad. Sci. U.S.A. 104, 20151–20158.
Wilson-Gerwing, T.D., Dmyterko, M.V., Zochodne, D.W., Johnston, J.M., and Verge, V.M. (2005). Neurotrophin-3 suppresses thermal hyperalgesia associated with neuropathic pain and attenuates transient receptor potential vanilloid receptor-1 expression in adult sensory neurons. J. Neurosci. 25, 758–767.
Woolf, C.J. and Mannion, R.J. (1999). Neuropathic pain: aetiology, symptoms, mechanisms, and management. Lancet 353, 1959–1964.
Wu, G., Ringkamp, M., Hartke, T.V., Murinson, B.B., Campbell, J.N., Griffin, J.W., and Meyer, R.A. (2001). Early onset of spontaneous activity in uninjured C-fiber nociceptors after injury to neighboring nerve fibers. J. Neurosci. 21, RC140.
Xiao, H.S., Huang, Q.H., Zhang, F.X., Bao, L., Lu, Y.J., Guo, C., Yang, L., Huang, W.J., Fu, G., Xu, S.H., Cheng, X.P., Yan, Q., Zhu, Z.D., Zhang, X., Chen, Z., Han, Z.G., and Zhang, X. (2002). Identification of gene expression profile of dorsal root ganglion in the rat peripheral axotomy model of neuropathic pain. Proc. Natl. Acad. Sci. U.S.A. 99, 8360–8365.
Xu, J.T., Xin, W.J., Wei, X.H., Wu, C.Y., Ge, Y.X., Liu, Y.L., Zang, Y., Zhang, T., Li, Y.Y., and Liu, X.G. (2007). p38 activation in uninjured primary afferent neurons and in spinal microglia contributes to the development of neuropathic pain induced by selective motor fiber injury. Exp. Neurol. 204, 355–365.
Yamanaka, H., Obata, K., Kobayashi, K., Dai, Y., Fukuoka, T., and Noguchi, K. (2007). Activation of fibroblast growth factor receptor by axotomy, through downstream p38 in dorsal root ganglion, contributes to neuropathic pain. Neuroscience 150, 202–211.
Zhang, J., Shi, X.Q., Echeverry, S., Mogil, J.S., De Koninck, Y., and Rivest, S. (2007). Expression of CCR2 in both resident and bone marrow-derived microglia plays a critical role in neuropathic pain. J. Neurosci. 27, 12396–12406.
Zhuang, Z.Y., Gerner, P., Woolf, C.J., and Ji, R.R. (2005). ERK is sequentially activated in neurons, microglia, and astrocytes by spinal nerve ligation and contributes to mechanical allodynia in this neuropathic pain model. Pain 114, 149–159.
Zhuang, Z.Y., Kawasaki, Y., Tan, P.H., Wen, Y.R., Huang, J., and Ji, R.R. (2007). Role of the CX3CR1/p38 MAPK pathway in spinal microglia for the development of neuropathic pain following nerve injury-induced cleavage of fractalkine. Brain Behav Immun. 21, 642–651.
Zhuang, Z.Y., Wen, Y.R., Zhang, D.R., Borsello, T., Bonny, C., Strichartz, G.R., Decosterd, I., and Ji, R.R. (2006). A peptide c-Jun N-terminal kinase (JNK) inhibitor blocks mechanical allodynia after spinal nerve ligation: respective roles of JNK activation in primary sensory neurons and spinal astrocytes for neuropathic pain development and maintenance. J. Neurosci. 26, 3551–3560.
Acknowledgments
The work was supported in part by NIH grants NS40698, DE17794, and TW7180.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2009 Springer Science+Business Media, LLC
About this chapter
Cite this chapter
Ji, RR. (2009). MAP Kinase and Cell Signaling in DRG Neurons and Spinal Microglia in Neuropathic Pain. In: Malcangio, M. (eds) Synaptic Plasticity in Pain. Springer, New York, NY. https://doi.org/10.1007/978-1-4419-0226-9_20
Download citation
DOI: https://doi.org/10.1007/978-1-4419-0226-9_20
Published:
Publisher Name: Springer, New York, NY
Print ISBN: 978-1-4419-0225-2
Online ISBN: 978-1-4419-0226-9
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)